The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Andrew.Apps@glasgow.ac.uk
Golden Jubilee national hospital, Agamemnon Street, Clydebank, Glasgow, G814DY
Sykes, R. et al. (2026) Stratified medicine with eplerenone for myocardial infarction or injury and no obstructive coronary arteries: a registry-based basket trial. American Heart Journal, 301, 107518. (doi: 10.1016/j.ahj.2026.107518) (PMID:42392556)
Sykes, R. et al. (2023) Rationale and design of the effect of mineralocorticoid receptor antagonist therapy in patients with acute myocardial infarction or injury and non-obstructive coronary arteries: A registry-based, stratified-medicine, randomised, controlled trial. British Society of Cardiovascular Magnetic Resonance (BSCMR) 17th Annual Congress, Liverpool, UK, 11-12 Oct 2022. (doi: 10.1136/heartjnl-2022-BSCMR.26)
Sykes, R. et al. (2026) Stratified medicine with eplerenone for myocardial infarction or injury and no obstructive coronary arteries: a registry-based basket trial. American Heart Journal, 301, 107518. (doi: 10.1016/j.ahj.2026.107518) (PMID:42392556)
Sykes, R. et al. (2023) Rationale and design of the effect of mineralocorticoid receptor antagonist therapy in patients with acute myocardial infarction or injury and non-obstructive coronary arteries: A registry-based, stratified-medicine, randomised, controlled trial. British Society of Cardiovascular Magnetic Resonance (BSCMR) 17th Annual Congress, Liverpool, UK, 11-12 Oct 2022. (doi: 10.1136/heartjnl-2022-BSCMR.26)